A phase I study of a tumor-targeted nanoshell in five patients documents an important milestone in the development of nanoparticles for molecular imaging in humans (Phillips et al., this issue).
No takes yet. Share an insight, caveat, or question.
Peter L. Choyke (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: